Institute for Protein Innovation
- Research works
- 28 ▲ 1133% vs 2013–17
- Citations
- 1.2k 44.6 per fractional work
- Top-10% rate
- 24.5% record average 16.5%
- Open access
- 56% world 28%
Not ranked overall: Institute for Protein Innovation is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 6.7×. Every wedge is a field page.
Which keywords describe research at Institute for Protein Innovation?
By fractional works in all years, weighted toward what it does more of than the world: Antiretroviral Therapy, Inflammation, Vaccine, Glycosylation, Prognostic Factors, Immune Response, Mutation and Cancer.
- Ribosome
- Immunity
- Monoclonal Antibodies
- Immune Response
- Oxidative Stress
- Cancer
- Antiretroviral Therapy
- Inflammation
- Vaccine
- Glycosylation
- Prognostic Factors
- Mutation
- Therapeutic Antibodies
- Innate Immunity
- Translation
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 15 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 15 words, with their numbers
- Inflammation3▲ 4.0×14 topics
- Antiretroviral Therapy2▲ 33×4 topics
- Vaccine2▲ 16×5 topics
- Cancer2▲ 4.3×11 topics
- Glycosylation2▲ 25×3 topics
- Oxidative Stress2▲ 3.1×11 topics
- Prognostic Factors2▲ 12×4 topics
- Immune Response1▲ 7.8×5 topics
- Mutation1▲ 30×3 topics
- Monoclonal Antibodies1▲ 27×3 topics
- Therapeutic Antibodies1▲ 30×2 topics
- Immunity1▲ 11×4 topics
- Innate Immunity1▲ 11×5 topics
- Ribosome1▲ 36×1 topic
- Translation1▲ 17×1 topic
Which research topics does Institute for Protein Innovation publish most on?
By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, SARS-CoV-2 and COVID-19 Research, Ferroptosis and cancer prognosis and Cancer Immunotherapy and Biomarkers.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
- 2 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
- 3 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 0 works
- 4 Cancer Immunotherapy and Biomarkers Oncology 0 works
- 5 Cancer Cells and Metastasis Oncology 0 works
- 6 Biochemical and Structural Characterization Molecular Biology 0 works
- 7 Cell Adhesion Molecules Research Immunology and Allergy 0 works
- 8 Neuroblastoma Research and Treatments Neurology 0 works
- 9 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
- 10 RNA and protein synthesis mechanisms Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Institute for Protein Innovation's research output changed?
Output in 2018–2022 was 1133% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Boston
- Boston University
- Massachusetts General Hospital
- Brigham and Women's Hospital
- Northeastern University
- Boston Children's Hospital
- Boston College
- Beth Israel Deaconess Medical Center
- General Electric (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.